Bioventix PLC (LON:BVXP - Get Free Report)'s share price reached a new 52-week low during trading on Thursday . The stock traded as low as GBX 2,905 ($35.90) and last traded at GBX 2,998 ($37.05), with a volume of 7773 shares changing hands. The stock had previously closed at GBX 3,025 ($37.38).
Bioventix Price Performance
The company has a market capitalization of £155.56 million, a PE ratio of 1,828.22 and a beta of 0.35. The firm has a 50-day moving average of GBX 3,286.74 and a 200 day moving average of GBX 3,728.47.
Insider Activity at Bioventix
In other news, insider Bruce Hiscock bought 24 shares of the stock in a transaction on Friday, November 22nd. The shares were bought at an average price of GBX 3,822 ($47.23) per share, with a total value of £917.28 ($1,133.56). 8.02% of the stock is currently owned by insiders.
About Bioventix
(
Get Free Report)
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Recommended Stories
Before you consider Bioventix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioventix wasn't on the list.
While Bioventix currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
